Skip to main content

Table 3 Acute toxicity

From: CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Toxicity

Grade 1 No. (%)

Grade 2 No. (%)

Grade 3 No. (%)

Grade 4 No. (%)

Hematological

    

  Leukocytopenia

9 (12.7)

6 (8.5)

4 (5.6)

2 (2.8)

  Thrombocytopenia

1 (1.4)

0

0

0

Non-hematological

    

  Diarrhea

21 (29.6)

14 (19.7)

16 (22.5)

0

  Cystitis

12 (16.9)

9 (12.7)

3 (4.2)

0

  Dermatitis

8 (8.5)

13 (18.3)

7 (9.9)

0

  Vomiting

4 (5.6)

3 (4.2)

0

0

  Hand-foot syndrome

4 (5.6)

2 (2.8)

0

0